mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.8 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |